Literature DB >> 1624122

Auxotrophy of Pseudomonas aeruginosa in cystic fibrosis.

R F Taylor1, M E Hodson, T L Pitt.   

Abstract

Seventy-four of 403 (18.4%) sputum isolates of Pseudomonas aeruginosa from 49 of 136 (36.0%) adults with cystic fibrosis (CF) were auxotrophic mutants. Two of 11 (18.2%) isolates of P. aeruginosa taken from patients with non-CF bronchiectasis were also auxotrophic. All 99 strains taken from non-bronchiectatic sources were prototrophic. Forty-six of 55 (83.6%) CF auxotrophs required one or more of 36 growth factors tested; the requirements for the remaining 9 isolates were not identified. Methionine was the sole factor required by 17 of 22 (77.3%) isolated which depended on a single factor. We conclude that auxotrophy is a feature of P. aeruginosa infection in cystic fibrosis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1624122     DOI: 10.1016/0378-1097(92)90716-2

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  10 in total

Review 1.  Clinical significance of microbial infection and adaptation in cystic fibrosis.

Authors:  Alan R Hauser; Manu Jain; Maskit Bar-Meir; Susanna A McColley
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

2.  Increased sputum amino acid concentrations and auxotrophy of Pseudomonas aeruginosa in severe cystic fibrosis lung disease.

Authors:  S R Thomas; A Ray; M E Hodson; T L Pitt
Journal:  Thorax       Date:  2000-09       Impact factor: 9.139

3.  Essential genome of Pseudomonas aeruginosa in cystic fibrosis sputum.

Authors:  Keith H Turner; Aimee K Wessel; Gregory C Palmer; Justine L Murray; Marvin Whiteley
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-16       Impact factor: 11.205

4.  Auxotrophy of Burkholderia (Pseudomonas) cepacia from cystic fibrosis patients.

Authors:  A L Barth; T L Pitt
Journal:  J Clin Microbiol       Date:  1995-08       Impact factor: 5.948

5.  Auxotrophic variants of Pseudomonas aeruginosa are selected from prototrophic wild-type strains in respiratory infections in patients with cystic fibrosis.

Authors:  A L Barth; T L Pitt
Journal:  J Clin Microbiol       Date:  1995-01       Impact factor: 5.948

6.  Adult cystic fibrosis: association of acute pulmonary exacerbations and increasing severity of lung disease with auxotrophic mutants of Pseudomonas aeruginosa.

Authors:  R F Taylor; M E Hodson; T L Pitt
Journal:  Thorax       Date:  1993-10       Impact factor: 9.139

7.  Agmatine accumulation by Pseudomonas aeruginosa clinical isolates confers antibiotic tolerance and dampens host inflammation.

Authors:  Jennifer L McCurtain; Adam J Gilbertsen; Clayton Evert; Bryan J Williams; Ryan C Hunter
Journal:  J Med Microbiol       Date:  2019-01-22       Impact factor: 2.472

8.  Interspecies Metabolic Complementation in Cystic Fibrosis Pathogens via Purine Exchange.

Authors:  Hafij Al Mahmud; Jiwasmika Baishya; Catherine A Wakeman
Journal:  Pathogens       Date:  2021-02-01

Review 9.  Adaptation and Evolution of Pathogens in the Cystic Fibrosis Lung.

Authors:  Paul J Planet
Journal:  J Pediatric Infect Dis Soc       Date:  2022-09-07       Impact factor: 5.235

10.  Elevated exopolysaccharide levels in Pseudomonas aeruginosa flagellar mutants have implications for biofilm growth and chronic infections.

Authors:  Joe J Harrison; Henrik Almblad; Yasuhiko Irie; Daniel J Wolter; Heather C Eggleston; Trevor E Randall; Jacob O Kitzman; Bethany Stackhouse; Julia C Emerson; Sharon Mcnamara; Tyler J Larsen; Jay Shendure; Lucas R Hoffman; Daniel J Wozniak; Matthew R Parsek
Journal:  PLoS Genet       Date:  2020-06-12       Impact factor: 5.917

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.